The influence of fish oil supplementation on plasma lipoproteins and arterial lipids in Vervet monkeys with established atherosclerosis

Abstract

There is controversy about whether supplementing diets with marine fish oil can regress, promote or prevent atherosclerosis. Therefore the effects of an Atlantic pilchard oil (FO) supplement and dietary change were measured in a proven atherosclerosis model. Vervet or African Green monkeys were fed an atherogenic diet (AD) for long enough to ensure progression before treatments started. Matched groups were then treated for 20 months, either by adding FO to the AD ( AD FO ), or by changing to a therapeutic diet with FO ( TD FO ). Control treatments consisted of supplementing with sunflower oil (SO) instead of FO, so that treatments were AD SO and TD SO . The same total polyunsaturates were supplied by the FO and SO and the dose of FO was realistic (2.5% of total energy). A reference group (R) received the TD with no oil supplements. Supplementing with FO did not change the concentrations of total, low or high density lipoprotein cholesterol in plasma. After The AD FO the intimas of aortas contained more total (p ≤ 0.001), free (p ≤ 0.05) and esterified (p ≤ 0.05) cholesterol, total phospholipid (p ≤ 0.01) and sphingomyelin (p ≤ 0.05) than after the AD SO . After FO supplementation eicosapentaenoic acid was significantly higher and arachidonic acid significantly lower in the plasma and aorta intima phosphatidylcholine. None of these changes was anti-atherogenic in terms of atherosclerosis measured in the same individuals (1). Nor did FO increase the efficacy of the TD.